Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels ...

Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for ...

Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce ...

Novo Nordisk is acquiring Akero Therapeutics for drug candidate efruxifermin, which executive say could be first and best in ...

Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Amazon is no stranger to experimenting in healthcare even if it means acknowledging failure. Its latest bold venture? In-office pharmacy kiosks at One Medical offices so patients can access their ...

From left to right: Moderator Michael Kalishman, chief venture officer, Sentara Health; Nick Culbertson, managing director, Techstars; Dr. Ngoc-Anh Nguyen, vice chair of research, Houston Methodist ...

Interoperability doesn’t start with a 9-1-1 call. It begins with a commitment to data quality, documentation integrity, and adherence to national standards across the system. For EMS, this means ...

DUOS, a technology-enabled service provider, has raised $130 million to expand its platform to more health plans across the country, it announced on Thursday. The Minneapolis-based company supports ...